Patent · US Expired

Substituted pyrimido[5,4-d]pyrimidine nucleosides

US5041542A · kind A · utility

10Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 1988
Grant dateAug 20, 1991
Priority date
Expiry dateJun 3, 2008

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

.alpha. and .beta.-ribonucleosides of substituted pyrimido[5,4-d]pyrimidines are used in treating malignant tumors in vivo. A novel synthesis for preparing these compounds and other related compounds is further disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.